Novonix files Form 6-K on securities quotation
Novonix Limited furnished a Form 6-K as a foreign private issuer for September 2025.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
6-K
Rhea-AI Filing Summary
Novonix Limited furnished a Form 6-K as a foreign private issuer for September 2025. The report lists Exhibit 99.1, described as an Appendix 2A titled “Application for quotation of securities” dated September 25, 2025. The filing is signed by Chief Financial Officer Robert Long.
Key Figures
Commission file number: 001-41208
Form type: Form 6-K
Exhibit number: Exhibit 99.1
+2 more
5 metrics
Commission file number
001-41208
SEC file number for Novonix Limited
Form type
Form 6-K
Report of foreign private issuer for September 2025
Exhibit number
Exhibit 99.1
Appendix 2A Application for quotation of securities
Exhibit date
September 25, 2025
Date of Appendix 2A application for quotation of securities
Filing date
September 25, 2025
Date shown below the CFO’s signature
Key Terms
Form 6-K, foreign private issuer, Form 20-F, Form 40-F, +1 more
5 terms
Form 6-K regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Form 20-F regulatory
"whether the registrant files or will file annual reports under cover of Form 20‑F"
Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.
Form 40-F regulatory
"whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F"
A Form 40-F is a standardized annual filing used by certain Canadian companies that trade in U.S. markets to give U.S. regulators and investors the same core financial statements and key disclosures they file in Canada. Think of it as a translated, formally packaged annual report that lets investors in a different marketplace compare a company’s results, governance and risks more easily, which reduces uncertainty and helps investment decisions.
Application for quotation of securities financial
"Appendix 2A (Application for quotation of securities) dated September 25, 2025."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Novonix (NVNXF) report in this September 2025 Form 6-K?
Novonix Limited reports the submission of a Form 6-K for September 2025. The filing primarily forwards Exhibit 99.1, an Appendix 2A titled “Application for quotation of securities” dated September 25, 2025, signed on behalf of the company by its Chief Financial Officer.
What is Exhibit 99.1 in Novonix (NVNXF)'s September 2025 Form 6-K?
Exhibit 99.1 is described as an Appendix 2A, titled “Application for quotation of securities,” dated September 25, 2025. It is attached to Novonix Limited’s Form 6-K to provide details relating to that application, though the excerpt does not include the exhibit’s full contents.
Who signed Novonix (NVNXF)'s September 2025 Form 6-K?
The Form 6-K is signed on behalf of Novonix Limited by Robert Long, the company’s Chief Financial Officer. His electronic signature appears in the signature block, confirming the company has duly caused the report to be submitted under the Securities Exchange Act of 1934.
What type of issuer is Novonix (NVNXF) in this Form 6-K filing?
Novonix Limited is identified as a foreign private issuer in this Form 6-K. The document references whether the company files annual reports under cover of Form 20-F or Form 40-F, consistent with reporting requirements for foreign private issuers under U.S. securities regulations.
What is the commission file number in Novonix (NVNXF)'s Form 6-K?
The commission file number shown for Novonix Limited in this Form 6-K is 001-41208. This number is the company’s unique file identifier with the U.S. Securities and Exchange Commission and is used to associate its various filings across reporting periods.
AI-generated analysis. How Rhea-AI works. Not financial advice.
